ArticleViruses2024

Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial.

Kristian Braathen Malme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.